Dr. Hong is a patent agent specializing in patent prosecution in the field of biotechnology. She is experienced in preparing and prosecuting patent applications before the U.S. Patent and Trademark Office, as well as foreign patent offices. She also has aided in the preparation of a variety of legal opinions, addressing issues, such as patentability, inventorship, and the infringement, validity, and enforceability of patents. Dr. Hong additionally has participated in patent interference proceedings before the Board of Patent Appeals and Interferences.
The technical focus of applications that Dr. Hong has worked on includes, cancer vaccines, adoptive immunotherapy, gene therapy, microRNAs, cancer diagnostics, diabetes diagnostics, DNA microarrays, quantitative and real-time PCR methods, high protein foods, anti-diabetes and anti-cancer pharmaceuticals, including compounds and peptidomimetics, anti-addictive opioid drug formulations, nanoparticles, coated medical devices, plant transformation methods, and recombinant antibody production methods.
Most recently, Dr. Hong was a patent agent with an intellectual property firm based in Chicago. Prior to that experience, Dr. Hong was a graduate research assistant at Purdue University, working towards her thesis entitled “Regulation of B Cell Receptor Signaling through Differential Tyrosine Phosphorylation of Syk.” In 2001, she successfully completed her graduate studies and received a Ph.D. in Biochemistry and Molecular Biology. She received her B.S. in Chemistry with an emphasis in Biochemistry from Loyola University Chicago in 1997.
Dr. Hong is registered to practice before the U.S. Patent & Trademark Office.
Publications
Julie J. Hong, Regulation of Signaling in B Cells through the Phosphorylation of Syk on Linker Region Tyrosines, A Mechanism for Negative Signaling by the Lyn Tyrosine Kinase, Journal of Biological Chemistry, 277: 31703-31714 (2002).
Julie J. Hong, The Engagement of b1 Integrins on Promonocytic Cells Promotes Phosphorylation of Syk and Formation of a Protein Complex Containing Lyn and b1 Integrin, European Journal of Immunology 29; 1426-1434 (1999).